from Reuters: Health News https://ift.tt/2u3L38V
via IFTTT
Monday, December 30, 2019
AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer
AstraZeneca and Merck's ovarian cancer drug Lynparza has received U.S. regulatory approval for the treatment of advanced pancreatic cancer, cementing its lead in a niche category of cancer treatments.
from Reuters: Health News https://ift.tt/2u3L38V
via IFTTT
from Reuters: Health News https://ift.tt/2u3L38V
via IFTTT
0 comments:
Post a Comment